- Home
- SIMO vs RARE Comparison
SIMO vs RARE Comparison
Compare SIMO & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIMO | RARE |
|---|---|---|
| Founded | 1995 | 2010 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.2B |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SIMO | RARE |
|---|---|---|
| Price | $87.45 | $36.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 15 |
| Target Price | ★ $103.13 | $85.20 |
| AVG Volume (30 Days) | 348.7K | ★ 1.4M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | ★ 8.75 | N/A |
| EPS | ★ 2.87 | N/A |
| Revenue | ★ $798,326,000.00 | $630,598,000.00 |
| Revenue This Year | $10.15 | $19.09 |
| Revenue Next Year | $17.72 | $20.62 |
| P/E Ratio | $30.56 | ★ N/A |
| Revenue Growth | N/A | ★ 20.63 |
| 52 Week Low | $37.21 | $25.81 |
| 52 Week High | $106.60 | $49.19 |
Technical Indicators
Market Signals| Indicator | SIMO | RARE |
|---|---|---|
| Relative Strength Index (RSI) | 43.88 | 60.60 |
| Support Level | $86.56 | $35.65 |
| Resistance Level | $96.77 | $36.74 |
| Average True Range (ATR) | 3.05 | 1.38 |
| MACD | 0.24 | 0.13 |
| Stochastic Oscillator | 37.50 | 52.24 |
Price Performance
Historical ComparisonAbout SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.